Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma

BACKGROUND: Elafin is a serine protease inhibitor critical for host defence. We previously reported that Elafin was associated with the recurrence of early-stage hepatocellular carcinoma (HCC) after surgery. However, the exact role of Elafin in HCC remains obscure. METHODS: HCC tissue microarrays we...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chenwei, Liao, Yadi, He, Wei, Zhang, Hong, Zuo, Dinglan, Liu, Wenwu, Yang, Zhiwen, Qiu, Jiliang, Yuan, Yichuan, Li, Kai, Zhang, Yuanping, Wang, Yongjin, Shi, Yunxing, Qiu, Yuxiong, Gao, Song, Yuan, Yunfei, Li, Binkui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995733/
https://www.ncbi.nlm.nih.gov/pubmed/33771199
http://dx.doi.org/10.1186/s13046-021-01904-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995733/
https://www.ncbi.nlm.nih.gov/pubmed/33771199
http://dx.doi.org/10.1186/s13046-021-01904-y

Ejemplares similares